日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma

抗PD-1抑制剂联合白蛋白紫杉醇治疗中国难治性黑色素瘤患者的疗效和安全性

Li, Jing-Jing; Wang, Jiu-Hong; Dingv, Ya; Li, Dan-Dan; Wen, Xi-Zhi; Zhao, Jing-Jing; Jiang, Hang; Liu, Xing; Huang, Fu-Xue; Zhang, Xiao-Shi